Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Lynne Fox currently holds 120,481 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Lynne Fox has been a net neutral trader of EBS stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Lynne Fox's most recent insider trade was on Sep 3, 2025, when they sold 4,435 shares at $6.80 per share.
Jennifer Lynne Fox serves as Executive at Emergent BioSolutions Inc. (EBS). They have executed 21 insider transactions totaling $0 over their tenure at the company.
Jennifer Lynne Fox holds the position of Executive at Emergent BioSolutions Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Jennifer Lynne Fox has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jennifer Lynne Fox was on Sep 3, 2025, when they sold $30.2K worth of MYGN shares. This transaction involved 4,435 shares at $6.80 per share.
Jennifer Lynne Fox currently owns 120,481 shares of Emergent BioSolutions Inc. (EBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Lynne Fox's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Lynne Fox has 21 Form 4 filings on record as an insider at Emergent BioSolutions Inc..
Set alerts for Jennifer Lynne Fox and 40,000+ other insiders.